Guardant Health GH
NASDAQ GH
$182.99 +8.09 (+4.63%)
As of: Sep 17, 2026 · 3:59 PM EDT

Guardant Health (GH) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)

Analysis

Guardant Health (GH) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 15.47%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 10.22%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 16.51%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -18.19%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 28.59%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 31.64%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 30.27%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 72.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.19%
Mar 31, 2026 5.67%
Dec 31, 2025 2.80%
Sep 30, 2025 16.97%
Jun 30, 2025 24.21%
Mar 31, 2025 8.26%
Dec 31, 2024 -6.88%
Sep 30, 2024 -0.07%
Jun 30, 2024 -1.70%
Mar 31, 2024 -1.59%
Dec 31, 2023 -25.89%
Sep 30, 2023 -3.50%
Jun 30, 2023 -10.02%
Mar 31, 2023 -68.87%
Dec 31, 2022 -77.06%
Sep 30, 2022 -133.10%
Jun 30, 2022 -170.44%
Mar 31, 2022 -67.87%
Dec 31, 2021 -53.53%
Sep 30, 2021 -63.82%